Evidence map›Paper›PMID 23917455›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2013

Specialty supplement use and biologic measures of oxidative stress and DNA damage.

Elizabeth D Kantor, Cornelia M Ulrich, Robert W Owen, Peter Schmezer, Marian L Neuhouser, Johanna W Lampe, Ulrike Peters, Danny D Shen, Thomas L Vaughan, Emily White

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Elizabeth D KantorAuthors' Affiliations: Public Health Sciences Division, Clinical Research Division, Fred Hutchinson Cancer Research Center; Departments of Epidemiology, Pharmacy, and Pharmaceutics, University of Washington, Seattle, Washington; Division of Preventive Oncology, National Center for Tumor Diseases; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center, Heidelberg, Germany.
Cornelia M Ulrich
Robert W Owen
Peter Schmezer
Marian L Neuhouser
Johanna W Lampe
Ulrike Peters
Danny D Shen
Thomas L Vaughan
Emily White
National Center for Tumor Diseases · DEEpigenomics (Germany) · DEFred Hutch Cancer Center · USUniversity of Washington · USGerman Cancer Research Center · DE

Funding

Cancer Prevention Trng-Nutrition, Exercise &GeneticsR25CA094880 · NCI · UNIVERSITY OF WASHINGTON · PI WHITE, EMILY · 2002 to 2016
$7.3M
ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION AND CONTROLK05CA124911 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VAUGHAN, THOMAS L · 2007 to 2016
$1.6M
Cohort Study of Glucosamine and Chondroitin Supplement Use and Cancer RiskR01CA142545 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI WHITE, EMILY · 2010 to 2012
$910k
Established Investigator Award Anti-Inflammatory Exposures in Cancer PreventionK05CA154337 · NCI · UNIVERSITY OF WASHINGTON · PI WHITE, EMILY · 2011 to 2015
$637k
USE OF ANTIOXIDANT SUPPLEMENTS AND OXIDATIVE DNA DAMAGER03CA105336 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEUHOUSER, MARIAN L · 2005 to 2006
$160k
NCI NIH HHS K05 CA124911NCI NIH HHS K05CA124911NCI NIH HHS K05 CA154337NCI NIH HHS K05CA154337NCI NIH HHS R01 CA142545NCI NIH HHS R01CA142545NCI NIH HHS R03 CA105336NCI NIH HHS R03CA105336NCI NIH HHS R25 CA094880NCI NIH HHS R25CA094880
6 · The paper itself

Abstract

backgroundOxidative stress and resulting cellular damage have been suggested to play a role in the etiology of several chronic diseases, including cancer and cardiovascular disease. Identifying factors associated with reduced oxidative stress and resulting damage may guide future disease-prevention strategies.

methodsIn the VITamins And Lifestyle (VITAL) biomarker study of 209 persons living in the Seattle area, we examined the association between current use of several specialty supplements and oxidative stress, DNA damage, and DNA repair capacity. Use of glucosamine, chondroitin, fish oil, methylsulfonylmethane (MSM), coenzyme Q10 (CoQ10), ginseng, ginkgo, and saw palmetto was ascertained by a supplement inventory/interview, whereas the use of fiber supplements was ascertained by questionnaire. Supplements used by more than 30 persons (glucosamine and chondroitin) were evaluated as the trend across number of pills/week (non-use, <14 pills/week, 14+ pills/week), whereas less commonly used supplements were evaluated as use/non-use. Oxidative stress was measured by urinary 8-isoprostane and PGF2α concentrations using enzyme immunoassays (EIA), whereas lymphocyte DNA damage and DNA repair capacity were measured using the Comet assay. Multivariate-adjusted linear regression was used to model the associations between supplement use and oxidative stress/DNA damage.

resultsUse of glucosamine (Ptrend: 0.01), chondroitin (Ptrend: 0.003), and fiber supplements (P: 0.01) was associated with reduced PGF2α concentrations, whereas CoQ10 supplementation was associated with reduced baseline DNA damage (P: 0.003).

conclusionsUse of certain specialty supplements may be associated with reduced oxidative stress and DNA damage. IMPACT: Further research is needed to evaluate the association between specialty supplement use and markers of oxidative stress and DNA damage.

Indexed as

Dietary SupplementsDNA DamageAgedChondroitinFemaleGlucosamineHumansLife StyleMaleMiddle AgedOxidative StressRisk FactorsSurveys and QuestionnairesChondroitinGlucosamine

Identifiers

PMID23917455
PMCPMC3901246
OpenAlexW2096616843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.